The FDA's position is that efficacy above 15 mg is unproven, and the risk-benefit ratio is unknown
5 Based on their findings, Carroll and Kelley advise that until more rigorous studies (randomized, controlled trials with diverse menopausal patient populations at least 12 weeks in duration or longer) are conducted to assess their use in the management of hot flashes, duloxetine, escitalopram, fluvoxamine, and mirtazapine (see below) should be reserved as last-line therapy
And dont forget to drink 810 glasses of water daily staying hydrated helps the fiber do its job and keeps constipation at bay
As these medications continue to shape the future of diabetes care, ongoing research and clinical insights will further illuminate their roles in optimizing patient outcomes.
Inactive ingredients in this product are: Vegetable glycerin, water, natural flavorings, fructose and potassium sorbate
Treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to severe liver fibrosis